Developmental Features of Human Striatal Tissue Transplanted in a Rat Model of Huntington's Disease
暂无分享,去创建一个
[1] S. Dunnett,et al. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics , 1997, Neuroscience.
[2] O. Isacson,et al. Cytoarchitectonic Development, Axon-Glia Relationships, and Long Distance Axon Growth of Porcine Striatal Xenografts in Rats , 1994, Experimental Neurology.
[3] P. Sanberg,et al. Development of the human striatum: implications for fetal striatal transplantation in the treatment of Huntington's disease. , 1995, Cell transplantation.
[4] K. Meiri,et al. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Kupsch,et al. Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function , 1994, Brain Research.
[6] A. Björklund,et al. Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence , 1995, Neuroscience.
[7] A. Graybiel,et al. Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[8] K. Shannon,et al. Neural Transplantation for Huntington's Disease: Experimental Rationale and Recommendations for Clinical Trials , 1996, Cell transplantation.
[9] Jirăsek Je. Developmental stages of human embryos. , 1978 .
[10] 田中 一成,et al. 生検心筋細胞内PCNA(proliferating cell nuclear antigen)の検出 , 1992 .
[11] K. Janeczko. Co-expression of GFAP and vimentin in astrocytes proliferating in response to injury in the mouse cerebral hemisphere. A combined autoradiographic and double immunocytochemical study , 1993, International Journal of Developmental Neuroscience.
[12] N. Azumi,et al. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. , 1987, American journal of clinical pathology.
[13] W. Low,et al. The fate of human glial cells following transplantation in normal rodents and rodent models of neurodegenerative disease , 1995, Brain Research.
[14] O. Isacson,et al. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence , 1994, Brain Research.
[15] M. Levivier,et al. Time course of the neuroprotective effect of transplantation on quinolinic acid-induced lesions of the striatum , 1995, Neuroscience.
[16] A. Björklund,et al. Development of intrastriatal striatal grafts and their afferent innervation from the host , 1991, Neuroscience.
[17] O. Lindvall,et al. Phenotypic development of the human embryonic striatal primordium: A study of cultured and grafted neurons from the lateral and medial ganglionic eminences , 1996, Neuroscience.
[18] J. Boya,et al. Co-expression of glial fibrillary acidic protein and vimentin in reactive astrocytes following brain injury in rats. , 1991, Brain research.
[19] P. Brundin,et al. Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32-containing neurones. , 1994, Neuroreport.
[20] Ronan O'Rahilly,et al. The embryonic human brain , 1994 .
[21] A. Björklund,et al. Intrinsic Organization and Connectivity of Intrastriatal Striatal Transplants in Rats as Revealed by DARPP‐32 Immunohistochemistry: Specificity of Connections with the Lesioned Host Brain , 1989, The European journal of neuroscience.
[22] G. Banker,et al. Development of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones , 1988, Nature.
[23] K. Weber,et al. Vimentin, the 57 000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. , 1981, European journal of cell biology.
[24] D. Schiffer,et al. Reactive cell proliferation and microglia following injury to the rat brain , 1994, Neuropathology and applied neurobiology.
[25] R Myers,et al. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain II. Correlation between positron emission tomography and reaching behaviour , 1997, Neuroscience.
[26] K Weber,et al. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Grasbon-Frodl,et al. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease , 1996, Neuroscience.
[28] E. Grasbon-Frodl,et al. Antioxidant treatment protects striatal neurons against excitotoxic insults , 1996, Neuroscience.
[29] D. Schiffer,et al. Immunohistochemistry of glial reaction after injury in the rat: Double stainings and markers of cell proliferation , 1993, International Journal of Developmental Neuroscience.
[30] K. Meiri,et al. Distribution and phosphorylation of the growth-associated protein GAP- 43 in regenerating sympathetic neurons in culture , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[31] W. Low,et al. Transplantation of human striatal tissue into a rodent model of Huntington's disease: Phenotypic expression of transplanted neurons and host-to-graft innervation , 1996, Brain Research Bulletin.
[32] D. Price,et al. A modified histochemical technique to visualize acetylcholinesterase-containing axons. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[33] Immunocytochemical localization of growth-associated protein GAP-43 in early human development. , 1995, Brain research. Developmental brain research.
[34] P. Brundin,et al. Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease , 1996, Neuroscience.
[35] A. Bjo¨rklund,et al. Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat , 1987, Neuroscience.
[36] M. Graeber,et al. The microglial cytoskeleton: vimentin is localized within activated cellsin situ , 1988, Journal of neurocytology.
[37] M. Peschanski,et al. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease , 1995, Neuroscience.
[38] A. Björklund,et al. Host regulation of glial markers in intrastriatal grafts of conditionally immortalized neural stem cell lines , 1996, Neuroreport.
[39] S. Juliano,et al. Long-term delayed vascularization of human neural transplants to the rat brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[40] D. Riche,et al. Ontogeny of Human Striatal DARPP-32 Neurons in Fetuses and Following Xenografting to the Adult Rat Brain , 1996, Experimental Neurology.
[41] L. Rakić,et al. GAP-43 mRNA expression in early development of human nervous system. , 1996, Brain research. Molecular brain research.
[42] R. Stam,et al. The expression of GAP-43 mRNA in developing embryonic striatal tissue grafts. , 1993, Neuroreport.